Concepedia

Karel Odrážka

KO

Statistics

Publications

23

Citations

1.7K

H-Index

15

Active since

2001

Affiliations

Charles University(Current)

University Hospital Hradec Králové

Pardubice Region

University of Pardubice

University of Calgary

Karel Odrážka is an author at Charles University specializing in medicine, oncology, and radiation therapy.

ORCID

Publications per year

2001–2018

23

Publications

23

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

, , +13

Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey

Cai Grau, Noémie Defourny, Julian Malicki et al. · Radiotherapy and Oncology · 2014 · 177 citations · Full text

, , +10

Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

Jiří Doležal, J Vizdá, Karel Odrážka · Urologia Internationalis · 2006 · 42 citations

, , +17

Dose Escalation in Prostate Radiotherapy up to 82 Gy Using Simultaneous Integrated Boost

Martin Doležel, Karel Odrážka, Miloslava Vaculíková et al. · Strahlentherapie und Onkologie · 2010 · 41 citations

, , +13

Time course of late rectal toxicity after radiation therapy for prostate cancer

Karel Odrážka, Martin Doležel, J Vaňásek et al. · Prostate Cancer and Prostatic Diseases · 2009 · 35 citations

, , +17

1–5 of 23